Lives before profits: India issues first compulsory license
Linkedin

Lives before profits: India issues first compulsory license

Mumbai : India | Mar 13, 2012 at 3:01 PM PDT
Source: Asian Tribune
XX XX
Views: Pending
 
21 — editor In a landmark case, the Indian Patent Office has issued the first-ever compulsory license in India to a generic drug manufacturer. This effectively ends German pharmaceutical company Bayer's monopoly in India on the drug sorafenib tosylate used to treat kidney and liver cancer. FULL ARTICLE AT Asian Tribune
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

News Stories

 
  • A historic move to make drugs affordable

    The Hindu
    Aspects of Intellectual Property Rights and the Doha Declaration provide for compulsory licensing in specified circumstances, including concerns on public health or public interest. Licence till 2021 Mere application of the test of reasonable price...
  • We will intervene to make critical drugs...

    Indian Express
    The Controller General of Patents, Designs and Trademarks had on Monday allowed Hyderabad-headquartered Natco Pharma to manufacture a generic version of Nexawar or Sorafenib, a cancer drug patented by Bayer in 2008. Commerce and Industry Minister...

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.